메뉴 건너뛰기




Volumn 22, Issue 3, 2007, Pages 427-430

Exercise improves efficacy of levodopa in patients with Parkinson's disease

Author keywords

Efficacy; Exercise; Levodopa; Parkinson's disease

Indexed keywords

BENSERAZIDE; DOMPERIDONE; LEVODOPA;

EID: 34147135545     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21346     Document Type: Article
Times cited : (58)

References (10)
  • 1
    • 0031697688 scopus 로고    scopus 로고
    • Enhanced fatigue during motor performance in patients with Parkinson's disease
    • Ziv I, Avraham M, Michaelov Y, et al. Enhanced fatigue during motor performance in patients with Parkinson's disease. Neurology 1998;51:1583-1586.
    • (1998) Neurology , vol.51 , pp. 1583-1586
    • Ziv, I.1    Avraham, M.2    Michaelov, Y.3
  • 2
    • 0026794991 scopus 로고
    • The effect of exercise on levodopa absorption
    • Carter JH, Nutt JG, Woodward WR. The effect of exercise on levodopa absorption. Neurology 1992;42:2042-2045.
    • (1992) Neurology , vol.42 , pp. 2042-2045
    • Carter, J.H.1    Nutt, J.G.2    Woodward, W.R.3
  • 3
    • 0027270391 scopus 로고
    • Blood levodopa levels and unified Parkinson's disease rating scale function: With and without exercise
    • Goetz CG, Thelen JA, MacLeod CM, Carvey PM, Bartley EA, Stebbins GT. Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise. Neurology 1993;43:1040-1042.
    • (1993) Neurology , vol.43 , pp. 1040-1042
    • Goetz, C.G.1    Thelen, J.A.2    MacLeod, C.M.3    Carvey, P.M.4    Bartley, E.A.5    Stebbins, G.T.6
  • 5
    • 0033809616 scopus 로고    scopus 로고
    • The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa
    • Reuter I, Harder S, Engelhardt M, Baas H. The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa. Mov Disord 2000;15:862-868.
    • (2000) Mov Disord , vol.15 , pp. 862-868
    • Reuter, I.1    Harder, S.2    Engelhardt, M.3    Baas, H.4
  • 6
    • 33646946771 scopus 로고    scopus 로고
    • Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients
    • Müller T, Erdmann C, Bremen D, et al. Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients. Clin Neuropharmacol 2006;29:61-67.
    • (2006) Clin Neuropharmacol , vol.29 , pp. 61-67
    • Müller, T.1    Erdmann, C.2    Bremen, D.3
  • 7
    • 0342803654 scopus 로고    scopus 로고
    • Levodopa in plasma correlates with body weight of parkinsonian patients
    • Müller T, Woitalla D, Saft C, Kuhn W. Levodopa in plasma correlates with body weight of parkinsonian patients. Parkinsonism Relat Disord 2000;6:171-173.
    • (2000) Parkinsonism Relat Disord , vol.6 , pp. 171-173
    • Müller, T.1    Woitalla, D.2    Saft, C.3    Kuhn, W.4
  • 8
    • 0035650616 scopus 로고    scopus 로고
    • Effects of opioid receptor activation on cardiovascular responses and extracellular monoamines within the rostral ventrolateral medulla during static contraction of skeletal muscle
    • Nauli SM, Maher TJ, Pearce WJ, Ally A. Effects of opioid receptor activation on cardiovascular responses and extracellular monoamines within the rostral ventrolateral medulla during static contraction of skeletal muscle. Neurosci Res 2001;41:373-383.
    • (2001) Neurosci Res , vol.41 , pp. 373-383
    • Nauli, S.M.1    Maher, T.J.2    Pearce, W.J.3    Ally, A.4
  • 9
    • 0036181480 scopus 로고    scopus 로고
    • Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions
    • Schad CA, Justice JB, Jr, Holtzman SG. Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions. J Pharmacol Exp Ther 2002;300:932-938.
    • (2002) J Pharmacol Exp Ther , vol.300 , pp. 932-938
    • Schad, C.A.1    Justice Jr, J.B.2    Holtzman, S.G.3
  • 10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.